APREPITANT | N209296 | HERON THERAPEUTICS INC
| Trial # | Patent | Type | Petitioner | Status | Filed | Decision |
|---|---|---|---|---|---|---|
| PGR2025-00035 | 12115254 | PGR | Azurity Pharmaceuticals, Inc. et al. | Discretionary Denial | 2025-02-28 | 2025-08-14 |
| PGR2025-00036 | 12115255 | PGR | Azurity Pharmaceuticals, Inc. et al. | Discretionary Denial | 2025-02-28 | 2025-08-14 |
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Heron Therapeutics, Inc. v. Baxter Healthcare Corporation et al 13 patentsANDA 220233aprepitant | D. Del. | 2025-12-23 | Active | — |
Heron Therapeutics, Inc. v. Qilu Pharmaceutical Co., Ltd. et al 13 patentsANDA 220608aprepitant | D. Del. | 2025-07-03 | Terminated 2025-11-06 | — |
| D. Del. | 2024-12-12 | Active | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 9561229 | Sep 18, 2035 | — | — | Yes | — | |
| 9808465 | Sep 18, 2035 | — | — | — | — | |
| 9974742 | Sep 18, 2035 | — | — | Yes | — | — |
| 9974793 | Sep 18, 2035 | — | — | Yes | — | — |
| 9974794 | Sep 18, 2035 | — | — | Yes | — | |
| 10500208 | Sep 18, 2035 | — | — | Yes | — | — |
| 10624850 | Sep 18, 2035 | — | — | — | — | |
| 10953018 | Sep 18, 2035 | — | — | — | — | |
| 11173118 | Sep 18, 2035 | — | — | Yes | — | — |
| 11744800 | Sep 18, 2035 | — | — | Yes | — | — |
| 12115254 | Sep 18, 2035 | — | — | Yes | — | — |
| 12115255 | Sep 18, 2035 | — | — | Yes | — | — |
| 12290520 | Sep 18, 2035 | — | — | Yes | — | — |